McDonnell Kevin J
Center for Precision Medicine, Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
J Clin Med. 2025 Mar 17;14(6):2040. doi: 10.3390/jcm14062040.
Oncologists increasingly recognize the microbiome as an important facilitator of health as well as a contributor to disease, including, specifically, cancer. Our knowledge of the etiologies, mechanisms, and modulation of microbiome states that ameliorate or promote cancer continues to evolve. The progressive refinement and adoption of "omic" technologies (genomics, transcriptomics, proteomics, and metabolomics) and utilization of advanced computational methods accelerate this evolution. The academic cancer center network, with its immediate access to extensive, multidisciplinary expertise and scientific resources, has the potential to catalyze microbiome research. Here, we review our current understanding of the role of the gut microbiome in cancer prevention, predisposition, and response to therapy. We underscore the promise of operationalizing the academic cancer center network to uncover the structure and function of the gut microbiome; we highlight the unique microbiome-related expert resources available at the City of Hope of Comprehensive Cancer Center as an example of the potential of team science to achieve novel scientific and clinical discovery.
肿瘤学家越来越认识到微生物群是健康的重要促进因素,也是包括癌症在内的疾病的促成因素。我们对改善或促进癌症的微生物群状态的病因、机制和调节的认识仍在不断发展。“组学”技术(基因组学、转录组学、蛋白质组学和代谢组学)的不断完善和应用,以及先进计算方法的运用加速了这一发展。学术癌症中心网络能够直接获取广泛的多学科专业知识和科学资源,有潜力推动微生物群研究。在此,我们回顾了目前对肠道微生物群在癌症预防、易感性和治疗反应中作用的理解。我们强调了利用学术癌症中心网络来揭示肠道微生物群的结构和功能的前景;我们以综合癌症中心希望之城可获得的独特的微生物群相关专家资源为例,强调团队科学在实现新的科学和临床发现方面的潜力。